About the Company
We do not have any company description for Nexalin Technology, Inc. at the moment.
Sector
Industrial Applications and Services
Industry
Electromedical & Electrotherapeutic Apparatus
Employees
20
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Nexalin Technology, Inc.
Nexalin Technology, Inc. to Host Investor Webinar Showcasing ... - Nasdaq
Nexalin Technology, Inc. invites investors to a webinar on June 3, 2025, at 4:15 p.m. ET, where CEO Mark White will present the company’s innovative Deep Intracranial Frequency Stimulation (DIFS ...
Nexalin Technology, Inc. Reports Landmark Study Highlights ... - Nasdaq
Nexalin Technology, Inc. Reports Landmark Study Highlights Efficacy of DIFS™ Technology in Reducing Blood Pressure in Patients with Major Depressive Disorder February 03, 2025 — 08:44 am EST ...
NXL - Nexalin Technology Inc News | Morningstar
News Nexalin Technology and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money (TM) Show on Bloomberg TV Accesswire Mar 14, 2025 6:00am ...
Nexalin Technology Secures USPTO Patent for Deep Intracranial Fre
Patent Approval Reinforces Nexalin’s Leadership in Non-Invasive Brain Stimulation for Addiction Treatment HOUSTON, TX, April 14, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL ...
Nexalin’s Breakthrough DIFS™ Neurostimulation Device Demonstrates ...
HOUSTON, TX, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) the leader in Deep Intracranial Frequency Stimulation (DIFS™) of ...
Nexalin Technology, Inc. Announces Pricing of $9.6 Million Initial ...
HOUSTON, TEXAS, Sept. 15, 2022 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (NXL) (the “Company” or “Nexalin”) today announced the pricing of its initial public offering of 2,315,000 units ...
Nexalin Technology Announces UCSD IRB Approval for use of HALO ...
David Owens, CMO of Nexalin Technology, added, “With the deployment of our first 50 HALO devices to UCSD, we are embarking on a critical phase in our mission to redefine neurostimulation therapy.
NXLIW Nexalin Technology, Inc. WT EXP - Seeking Alpha
Nexalin Technology, Inc. WT EXP SEC Filing - Securities Registration Statement (S-1) December 20, 2024 SEC FilingsFri, Dec. 20, 2024 ...
NXL - Nexalin Technology Inc Price vs Fair Value - Morningstar
Find out if Nexalin Technology Inc (NXL:XNAS) stock is overpriced or undervalued based on Morningstar's evaluation. Assess the current comparison of market prices to the Fair Value of the company ...
Nexalin Technology and Calidi Biotherapeutics Interviews to Air on the ...
/ March 14, 2025 / RedChip Companies will air interviews with Nexalin Technology, Inc. (Nasdaq:NXL) and Calidi Biotherapeutics, Inc. (NYSE American:CLDI) on the RedChip Small Stocks, Big Money ...
Nexalin Technology, Inc. Announces Closing of $9.6 Million Initial ...
HOUSTON, TEXAS, Sept. 20, 2022 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) today announced the closing of its previously announced initial public offering of ...
Similar Companies
Loading the latest forecasts...